Maker of Deadly Drug 50 Times Stronger Than Heroin Spends $500K to Fight Legal Pot

From Matt Agorist:

Insys Therapeutics, the company who makes insane profits from a drug behind one of the worst overdose epidemics in the nation’s history, fentanyl, has donated $500,000 to a campaign opposing marijuana legalization in the US state of Arizona.

In a glaring display of hypocrisy, the maker of the drug Subsys, a sublingual fentanyl spray, claims that marijuana is dangerous because it could hurt children.

#Prop205 doesn’t just legalize pot. It makes high-potency drug-laced candy accessible to unsuspecting kids.#NoOn205

— Center for Arizona P (@azpolicy) August 31, 2016


Why, exactly, is the maker of a highly addictive and deadly drug attempting to thwart the legalization of an amazingly beneficial plant? They want that market for themselves.

“They want to be able to push their far more addictive, far more harmful and far more dangerous opioid drugs,” JP Holyoak, chair of the committee pushing Prop 205, a bill that would legalize marijuana in Arizona, told the Arizona Capitol Times.

According to a study that looked at 17 states with medical cannabis laws in place, researchers “found that the use of prescription drugs for which marijuana could serve as a clinical alternative fell significantly, once a medical marijuana law was implemented.”

Prescriptions fell dramatically for opioid painkillers, with 1,826 fewer doses being prescribed per year by the typical physician in a medical cannabis state. Amazingly, the trend also applied to prescriptions for depression, seizure, nausea and anxiety.

When the researchers looked at data for conditions where medical cannabis is not used for treatment, prescription rates remain unchanged after the implementation of medical cannabis laws.

When they see their monopoly being challenged by a plant people can grow in their backyards, the pharmaceutical industry uses the state to remove their competition.

#YESon205 AZ Supreme Court Rules Legal Marijuana Measure Stays On Ballot

Continue Reading